Cargando…
Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer
Drug resistance is always a great obstacle in any endocrine therapy of breast cancer. Although the combination of endocrine therapy and targeted therapy has been shown to significantly improve prognosis, refractory endocrine resistance is still common. Dysregulation of the Hippo pathway is often rel...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194146/ https://www.ncbi.nlm.nih.gov/pubmed/34112175 http://dx.doi.org/10.1186/s12935-021-01999-5 |